The effectiveness and value of sotatercept for pulmonary arterial hypertension: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council

MeSH terms

• Advisory Committees
• Antihypertensive Agents / economics
• Antihypertensive Agents / therapeutic use
• Comparative Effectiveness Research
• Cost-Benefit Analysis
• Humans
• Pulmonary Arterial Hypertension* / drug therapy
• Pulmonary Arterial Hypertension* / economics
• Treatment Outcome
• United States